April 29, 2014 — GE Healthcare announced the first seven markets where Vizamyl (Flutemetamol F18 injection), a ...
April 17, 2014 — ICB Intl. Inc., (ICBI), announced the development of a tracer for imaging alpha-synuclein (a-Syn) in ...
April 16, 2014 — Navidea Biopharmaceuticals Inc. held an update meeting with the Committee for Medicinal Products for ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
April 4, 2014 — Researchers have discovered that microscopic "bubbles" developed at Kansas State University are safe and ...
April 1, 2014 — A minimally invasive treatment that delivers cancer-killing radiation directly to tumors shows promise ...
April 1, 2014 — Scientists at the Riken Center for Life Science Technologies in Kobe, Japan, have used PET (positron ...
Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...
March 20, 2014 — The U.S. Food and Drug Administration (FDA) approved a third beta-amyloid plaque positron emission ...
March 18, 2014 — Brain imaging using nuclear imaging radiotracers can detect early evidence of Alzheimer's disease that ...
March 7, 2014 — Navidea Biopharmaceuticals Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted ...
March 4, 2014 — Advanced Accelerator Applications (AAA), a growing international player in molecular nuclear medicine ...
February 28, 2014 — Navidea Biopharmaceuticals Inc. is a biopharmaceutical company focused on precision diagnostic ...
January 29, 2014 — Researchers are seeking to understand what happens inside the living brain after a concussion. In a ...
January 23, 2014 — An international research team at Icahn School of Medicine at Mount Sinai is testing a sugar-based ...
January 3, 2014 — As the global medical isotope shortage continues indefinitely following the plant leak in South Africa ...
The pursuit of an imaging tool to visualize the protein alpha-synuclein, the hallmark pathology of Parkinson's disease ...
Piramal Imaging announced today the European Union's Committee for Medicinal Products for Human Use (CHMP) recommended ...
November 20, 2013 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced that the U.S. Food and Drug ...
November 15, 2013 — For patients who fail to respond to current first-line and second-line treatments for colorectal ...
November 13, 2013 — Lantheus Medical Imaging, Inc., a developer, manufacturer and distributor of diagnostic imaging ...
November 8, 2013 — Zevacor Molecular, a healthcare firm that manufactures and distributes positron emissions tomography ...